PRESS RELEASE published on 10/05/2023 at 07:20, 1 year 1 month ago Gerresheimer AG: Gerresheimer on Track to Another Strong Financial Year
PRESS RELEASE published on 10/05/2023 at 07:00, 1 year 1 month ago Gerresheimer AG: Gerresheimer on track to another strong financial year
PRESS RELEASE published on 07/06/2023 at 07:20, 1 year 4 months ago Gerresheimer AG: Gerresheimer Continues Dynamic Growth in First Half of 2023
PRESS RELEASE published on 07/06/2023 at 07:00, 1 year 4 months ago Gerresheimer AG: Gerresheimer continues dynamic growth in first half of 2023
PRESS RELEASE published on 06/07/2023 at 16:08, 1 year 5 months ago Gerresheimer AG: Annual General Meeting backs growth course
PRESS RELEASE published on 04/18/2023 at 21:56, 1 year 7 months ago Gerresheimer AG: Gerresheimer AG successfully completes EUR 271.6 million capital increase
PRESS RELEASE published on 04/18/2023 at 21:53, 1 year 7 months ago EQS-Adhoc: Gerresheimer AG: Gerresheimer AG issues 3,140,000 million new shares at a placement price of EUR 86.50 per new share
PRESS RELEASE published on 04/18/2023 at 17:54, 1 year 7 months ago Gerresheimer AG: Gerresheimer AG launches cash capital increase with exclusion of shareholders' subscription rights through accelerated bookbuilding by up to 3,140,000 shares
PRESS RELEASE published on 04/18/2023 at 17:49, 1 year 7 months ago EQS-Adhoc: Gerresheimer AG: Gerresheimer AG launches cash capital increase with exclusion of shareholders' subscription rights through accelerated bookbuilding by up to 3,140,000 shares
PRESS RELEASE published on 04/06/2023 at 07:00, 1 year 7 months ago Gerresheimer AG: Gerresheimer with a good start to 2023 financial year: Again double-digit growth in revenues and Adjusted EBITDA
Published on 11/21/2024 at 22:05, 2 hours 9 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 2 hours 24 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 3 hours 59 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 4 hours 4 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 19:01, 5 hours 13 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 5 hours 38 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 6 hours 16 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 6 hours 23 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 6 hours 23 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 06:58, 17 hours 16 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 4 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 6 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 6 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 16 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
